首页 > 最新文献

medRxiv - Obstetrics and Gynecology最新文献

英文 中文
Dysphoric Milk Ejection Reflex: Risk, Prevalence, and Persistence 排乳反射障碍:风险、发生率和持续性
Pub Date : 2024-06-25 DOI: 10.1101/2024.06.25.24309475
Romy Cappenberg, Jesus Garcia Garcia, Christine Happle, Anna Zychlinsky Scharff
Background Dysphoric Milk Ejection Reflex (DMER), which affects a significant proportion of lactating parents and may significantly impact feeding choices, is poorly understood.
背景 对很多哺乳期父母都会出现的排乳反射障碍(DMER)知之甚少,它可能会严重影响喂养选择。
{"title":"Dysphoric Milk Ejection Reflex: Risk, Prevalence, and Persistence","authors":"Romy Cappenberg, Jesus Garcia Garcia, Christine Happle, Anna Zychlinsky Scharff","doi":"10.1101/2024.06.25.24309475","DOIUrl":"https://doi.org/10.1101/2024.06.25.24309475","url":null,"abstract":"<strong>Background</strong> Dysphoric Milk Ejection Reflex (DMER), which affects a significant proportion of lactating parents and may significantly impact feeding choices, is poorly understood.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"206 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141512600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic-free vaginal microbiota transplantation (VMT) changes vaginal microbiota and immune profile in women with asymptomatic dysbiosis: reporting of a randomized, placebo-controlled trial 无抗生素阴道微生物群移植(VMT)可改变无症状菌群失调妇女的阴道微生物群和免疫状况:一项随机、安慰剂对照试验的报告
Pub Date : 2024-06-25 DOI: 10.1101/2024.06.25.24309408
Elleke F. Bosma, Brynjulf Mortensen, Kevin DeLong, Mads Roepke, Helene Baek Juel, Randi Rich, Amalie Axelsen, Marouschka Scheeper, Rasmus Marvig, Thomas Gundelund Rasmussen, Colleen Acosta, Ulrich Binne, Anne Bloch Thomsen, Hans-Christian Ingerslev, Fareeha Zulfiqar, Tine Wroending, Paul Cotter, Marcus O'Brien, Shriram Patel, Sarita Dam, Julia Albert Nicholson, Henriette Svarre Nielsen, Timothy Dinan, Fergus McCarthy, Johan E.T. van Hylckama Vlieg, Laura M. Ensign
Here, we describe the first placebo-controlled trial of vaginal microbiota transplantation (VMT) in women with asymptomatic dysbiosis without the use of antibiotic pretreatment. Importantly, we also describe the implementation of a donor program and banking of donor cervicovaginal secretions (CVS) while retaining sample viability, which is crucial to allow for scale-up and confirmatory quality testing. By metagenome sequencing, we demonstrate that VMT provided a significant increase in combined Lactobacillus species in the active arm and strain-level genetic analysis confirmed Lactobacillus engraftment. Moreover, VMT was well tolerated and showed a good safety profile. Furthermore, a shift toward increased Lactobacillus was associated with a change in the expression profile of genes in the complement pathway to a more anti-inflammatory profile. Vaginal microbial and immune profile restoration using VMT may have a positive impact on a wide range of conditions in womens health.
在此,我们介绍了在无症状菌群失调妇女中进行阴道微生物群移植(VMT)的首个安慰剂对照试验,该试验无需进行抗生素预处理。重要的是,我们还介绍了供体计划的实施和供体宫颈阴道分泌物(CVS)的储存,同时保留了样本的活力,这对于扩大规模和进行确证质量检测至关重要。通过元基因组测序,我们证明了 VMT 能显著增加活性臂中的乳酸杆菌种类,菌株级遗传分析证实了乳酸杆菌的移植。此外,VMT 还具有良好的耐受性和安全性。此外,乳酸杆菌的增加与补体通路基因表达谱的变化有关,补体通路基因表达谱的变化更具有抗炎性。使用 VMT 恢复阴道微生物和免疫功能可能会对妇女健康的各种状况产生积极影响。
{"title":"Antibiotic-free vaginal microbiota transplantation (VMT) changes vaginal microbiota and immune profile in women with asymptomatic dysbiosis: reporting of a randomized, placebo-controlled trial","authors":"Elleke F. Bosma, Brynjulf Mortensen, Kevin DeLong, Mads Roepke, Helene Baek Juel, Randi Rich, Amalie Axelsen, Marouschka Scheeper, Rasmus Marvig, Thomas Gundelund Rasmussen, Colleen Acosta, Ulrich Binne, Anne Bloch Thomsen, Hans-Christian Ingerslev, Fareeha Zulfiqar, Tine Wroending, Paul Cotter, Marcus O'Brien, Shriram Patel, Sarita Dam, Julia Albert Nicholson, Henriette Svarre Nielsen, Timothy Dinan, Fergus McCarthy, Johan E.T. van Hylckama Vlieg, Laura M. Ensign","doi":"10.1101/2024.06.25.24309408","DOIUrl":"https://doi.org/10.1101/2024.06.25.24309408","url":null,"abstract":"Here, we describe the first placebo-controlled trial of vaginal microbiota transplantation (VMT) in women with asymptomatic dysbiosis without the use of antibiotic pretreatment. Importantly, we also describe the implementation of a donor program and banking of donor cervicovaginal secretions (CVS) while retaining sample viability, which is crucial to allow for scale-up and confirmatory quality testing. By metagenome sequencing, we demonstrate that VMT provided a significant increase in combined Lactobacillus species in the active arm and strain-level genetic analysis confirmed Lactobacillus engraftment. Moreover, VMT was well tolerated and showed a good safety profile. Furthermore, a shift toward increased Lactobacillus was associated with a change in the expression profile of genes in the complement pathway to a more anti-inflammatory profile. Vaginal microbial and immune profile restoration using VMT may have a positive impact on a wide range of conditions in womens health.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141505957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting IVF live birth probabilities using machine learning, center-specific and national registry-based models 利用机器学习、特定中心和基于国家登记册的模型预测试管婴儿活产概率
Pub Date : 2024-06-21 DOI: 10.1101/2024.06.20.24308970
Elizabeth T. Nguyen, Matthew G. Retzloff, Laura April Gago, John E. Nichols, John F. Payne, Barry A. Ripps, Michael Opsahl, Jeremy Groll, Ronald Beesley, Lorie Nowak, Gregory Neal, Jaye Adams, Trevor Swanson, Xiaocong Chen, Mylene W. M. Yao
Objective:To compare the performance of machine learning based, center-specific (MLCS) models and the US national registry-based, multicenter model (SART model) in predicting IVF live birth probabilities (LBPs) for 6 unrelated, geographically diverse US fertility centers. Design:Retrospective observational design. Subjects:Test sets comprised first IVF cycle data (2013-2022) extracted from a retrospective cohort of 4,645 patients at 6 fertility centers. Intervention or Exposure:The initial (MLCS1) and updated (MLCS2) models were compared against age control. MLSC2 and SART models were compared. Main Outcome Measures:Model validation metrics, reported in median and interquartile range (IQR), were compared using Wilcoxon signed-rank test: ROC AUC, posterior log-likelihood of odds ratio compared to age (PLORA), Precision-Recall (PR) AUC, F1 score and continuous net reclassification improvement (NRI). Results:MLCS1 and MLCS2 models showed improved AUC and PLORA compared to age control; MLCS1 models were validated using out-of-time test data. MLCS2 models showed improved PLORA 23.9 (IQR 10.2, 39.4) compared to 7.2 (IQR 3.6, 11.8) for MLCS1, p<0.05. MLCS2 showed higher median PR AUC at 0.75 (IQR 0.73, 0.77) compared to 0.69 (IQR 0.68, 0.71) for SART, p<0.05. In addition, the median F1 Score was higher for MLCS2 compared to SART model across predicted live birth probability (LBP) thresholds sampled at deciles at ≥40%, ≥50%, ≥60%, ≥70%. For example, at the 50% LBP threshold, MLCS2 had a median F1 score of 0.74 (IQR 0.72, 0.78) compared to 0.71 (IQR 0.68, 0.73) for SART. At these six centers, using the LBP threshold of ≥ 50%, MLCS2 models can identify ~84% of patients who would go on to have IVF live births, while the SART model can only identify ~75%. That means for every 100 patients who will have a first IVF cycle live birth, using LBR ≥ 50% as threshold, the MLCS2 model can identify 9 more such patients without overcalling or overestimating LBPs compared to the SART model. Conclusion:MLCS models accurately assign higher IVF LBPs to more patients compared to the SART model at 6 US fertility centers. We recommend testing a larger sample of fertility centers to evaluate generalizability of MLCS model benefits.
目的:比较基于机器学习的特定中心模型(MLCS)和基于美国国家登记处的多中心模型(SART 模型)在预测 6 个无关联、地理位置不同的美国生殖中心的试管婴儿活产概率(LBPs)方面的性能。设计:回顾性观察设计。受试者:测试集包括从 6 家生殖中心 4645 名患者的回顾性队列中提取的首个试管婴儿周期数据(2013-2022 年)。干预或暴露:初始模型(MLCS1)和更新模型(MLCS2)与年龄对照进行了比较。比较了MLSC2和SART模型。主要结果指标:模型验证指标(以中位数和四分位数间距(IQR)表示)采用Wilcoxon符号秩检验进行比较:ROC AUC、与年龄相比的几率比后验对数似然比(PLORA)、精确度-召回(PR)AUC、F1得分和连续净再分类改善(NRI)。结果:与年龄对照相比,MLCS1 和 MLCS2 模型的 AUC 和 PLORA 均有所提高;MLCS1 模型使用时间外测试数据进行了验证。与 MLCS1 的 7.2(IQR 3.6,11.8)相比,MLCS2 模型的 PLORA 提高了 23.9(IQR 10.2,39.4),p<0.05。MLCS2 的中位 PR AUC 为 0.75(IQR 0.73,0.77),高于 SART 的 0.69(IQR 0.68,0.71),p<0.05。此外,在预测活产概率(LBP)阈值≥40%、≥50%、≥60%、≥70%的十等分抽样中,MLCS2 的中位 F1 得分高于 SART 模型。例如,在 50% LBP 阈值时,MLCS2 的中位 F1 得分为 0.74(IQR 0.72,0.78),而 SART 的中位 F1 得分为 0.71(IQR 0.68,0.73)。在这六个中心,使用≥50%的LBP阈值,MLCS2模型可以识别约84%的患者将继续进行试管婴儿活产,而SART模型只能识别约75%的患者。这意味着,以LBR≥50%为阈值,每100名会在首个试管婴儿周期活产的患者中,MLCS2模型能比SART模型多识别出9名这样的患者,而不会过高或高估LBPs。结论:在美国的 6 家生殖中心,与 SART 模型相比,MLCS 模型能准确地为更多患者分配更高的 IVF LBP。我们建议对更多的生育中心样本进行测试,以评估MLCS模型效益的普遍性。
{"title":"Predicting IVF live birth probabilities using machine learning, center-specific and national registry-based models","authors":"Elizabeth T. Nguyen, Matthew G. Retzloff, Laura April Gago, John E. Nichols, John F. Payne, Barry A. Ripps, Michael Opsahl, Jeremy Groll, Ronald Beesley, Lorie Nowak, Gregory Neal, Jaye Adams, Trevor Swanson, Xiaocong Chen, Mylene W. M. Yao","doi":"10.1101/2024.06.20.24308970","DOIUrl":"https://doi.org/10.1101/2024.06.20.24308970","url":null,"abstract":"Objective:\u0000To compare the performance of machine learning based, center-specific (MLCS) models and the US national registry-based, multicenter model (SART model) in predicting IVF live birth probabilities (LBPs) for 6 unrelated, geographically diverse US fertility centers. Design:\u0000Retrospective observational design. Subjects:\u0000Test sets comprised first IVF cycle data (2013-2022) extracted from a retrospective cohort of 4,645 patients at 6 fertility centers. Intervention or Exposure:\u0000The initial (MLCS1) and updated (MLCS2) models were compared against age control. MLSC2 and SART models were compared. Main Outcome Measures:\u0000Model validation metrics, reported in median and interquartile range (IQR), were compared using Wilcoxon signed-rank test: ROC AUC, posterior log-likelihood of odds ratio compared to age (PLORA), Precision-Recall (PR) AUC, F1 score and continuous net reclassification improvement (NRI). Results:\u0000MLCS1 and MLCS2 models showed improved AUC and PLORA compared to age control; MLCS1 models were validated using out-of-time test data. MLCS2 models showed improved PLORA 23.9 (IQR 10.2, 39.4) compared to 7.2 (IQR 3.6, 11.8) for MLCS1, p&lt;0.05. MLCS2 showed higher median PR AUC at 0.75 (IQR 0.73, 0.77) compared to 0.69 (IQR 0.68, 0.71) for SART, p&lt;0.05. In addition, the median F1 Score was higher for MLCS2 compared to SART model across predicted live birth probability (LBP) thresholds sampled at deciles at ≥40%, ≥50%, ≥60%, ≥70%. For example, at the 50% LBP threshold, MLCS2 had a median F1 score of 0.74 (IQR 0.72, 0.78) compared to 0.71 (IQR 0.68, 0.73) for SART. At these six centers, using the LBP threshold of ≥ 50%, MLCS2 models can identify ~84% of patients who would go on to have IVF live births, while the SART model can only identify ~75%. That means for every 100 patients who will have a first IVF cycle live birth, using LBR ≥ 50% as threshold, the MLCS2 model can identify 9 more such patients without overcalling or overestimating LBPs compared to the SART model. Conclusion:\u0000MLCS models accurately assign higher IVF LBPs to more patients compared to the SART model at 6 US fertility centers. We recommend testing a larger sample of fertility centers to evaluate generalizability of MLCS model benefits.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141506016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of pregnancy termination and associated factors among married women in Papua New Guinea: a nationally representative cross-sectional survey 巴布亚新几内亚已婚妇女终止妊娠的流行率及相关因素:一项具有全国代表性的横断面调查
Pub Date : 2024-06-21 DOI: 10.1101/2024.06.19.24309129
McKenzie Maviso, Paula Z. Aines, Gracelyn P. Potjepat, Nancy Geregl, Glen D.L Mola, John W. Bolnga
BackgroundPregnancy termination or induced abortion is not decriminalized, and access to safe abortion services is largely unavailable in Papua New Guinea (PNG). However, the practice is common throughout the country. This study aimed to estimate the prevalence and determine factors associated with pregnancy termination among married women aged 15-49 in PNG.MethodsSecondary data from the 2016-2018 PNG Demographic and Health Survey (PNGDHS) was used. A total weighted samples of 6,288 married women were included. Complex Sample Analysis method was used to account for the cluster design and sample weight of the study. Chi-square tests and multivariable logistic regression were used to assess factors associated with pregnancy termination. Adjusted odds ratios (aORs) with 95% Confidence Intervals (CIs) were reported.ResultsThe prevalence of pregnancy termination was 5.3%. Nearly half (45.2%) of all pregnancy terminations occurred in the Highlands region. Women aged 35-44 years (aOR = 8.54; 95% CI: 1.61-45.26), not working (aOR = 6.17; 95% CI: 2.26-16.85), owned a mobile phone (aOR = 3.77; 95% CI: 1.60-8.84), and lived in urban areas (aOR = 5.66; 95% CI: 1.91-16.81) were more likely to terminate a pregnancy. Women who experienced intimate partner violence (IPV) were 2.27 times (aOR = 2.27; 95% CI: 1.17-4.41) more likely to terminate a pregnancy compared to those who did not experience IPV. Women with unplanned pregnancies were 6.23 times (aOR = 6.23; 95% CI: 2.61-14.87) more likely to terminate a pregnancy. Women who knew about modern contraceptive methods and made independent decisions for contraceptive use were 3.38 and 2.54 times (aOR = 3.38; 95% CI: 1.39-8.18 and aOR = 2.54; 95% CI: 1.18-5.45, respectively) more likely to terminate a pregnancy.ConclusionThe findings highlight the role of sociodemographic and maternal factors in pregnancy termination among married women in PNG. Maternal age, occupation, mobile phone ownership, place of residence, IPV, unplanned pregnancy, knowledge of modern contraceptive methods, and decision-maker for contraceptive use were significantly associated with pregnancy termination. Efforts aimed at reducing unplanned pregnancies and terminations should focus on improving easy access to contraceptives and comprehensive sexual and reproductive health education for married couples. Post-abortion care should also be integrated into the country's legal framework and added as an important component of existing sexual and reproductive health services.
背景巴布亚新几内亚(PNG)未将终止妊娠或人工流产非刑罪化,而且基本上无法获得安全的人工流产服务。然而,这种做法在全国各地都很普遍。本研究旨在估算巴布亚新几内亚 15-49 岁已婚女性中终止妊娠的流行率,并确定与之相关的因素。方法采用 2016-2018 年巴布亚新几内亚人口与健康调查(PNGDHS)的二次数据。共纳入了 6288 名已婚妇女的加权样本。研究采用了复杂样本分析方法,以考虑研究的分组设计和样本权重。采用卡方检验和多变量逻辑回归评估与终止妊娠相关的因素。结果终止妊娠的发生率为 5.3%。近一半(45.2%)的终止妊娠发生在高地地区。年龄在 35-44 岁(aOR = 8.54;95% CI:1.61-45.26)、没有工作(aOR = 6.17;95% CI:2.26-16.85)、拥有手机(aOR = 3.77;95% CI:1.60-8.84)和居住在城市地区(aOR = 5.66;95% CI:1.91-16.81)的女性更有可能终止妊娠。经历过亲密伴侣暴力(IPV)的妇女终止妊娠的可能性是未经历过 IPV 的妇女的 2.27 倍(aOR = 2.27;95% CI:1.17-4.41)。计划外怀孕的女性终止妊娠的可能性是计划外怀孕女性的 6.23 倍(aOR = 6.23;95% CI:2.61-14.87)。了解现代避孕方法并能独立决定是否使用避孕药具的妇女终止妊娠的可能性分别是其他人的 3.38 倍和 2.54 倍(aOR = 3.38;95% CI:1.39-8.18 和 aOR = 2.54;95% CI:1.18-5.45)。孕产妇的年龄、职业、手机拥有量、居住地、IPV、计划外怀孕、对现代避孕方法的了解以及避孕药具使用的决策者都与终止妊娠有很大关系。旨在减少计划外怀孕和终止妊娠的工作应侧重于改善已婚夫妇获得避孕药具的便利性以及全面的性健康和生殖健康教育。还应将流产后护理纳入国家法律框架,并将其作为现有性健康和生殖健康服务的重要组成部分。
{"title":"Prevalence of pregnancy termination and associated factors among married women in Papua New Guinea: a nationally representative cross-sectional survey","authors":"McKenzie Maviso, Paula Z. Aines, Gracelyn P. Potjepat, Nancy Geregl, Glen D.L Mola, John W. Bolnga","doi":"10.1101/2024.06.19.24309129","DOIUrl":"https://doi.org/10.1101/2024.06.19.24309129","url":null,"abstract":"<strong>Background</strong>\u0000Pregnancy termination or induced abortion is not decriminalized, and access to safe abortion services is largely unavailable in Papua New Guinea (PNG). However, the practice is common throughout the country. This study aimed to estimate the prevalence and determine factors associated with pregnancy termination among married women aged 15-49 in PNG.\u0000<strong>Methods</strong>\u0000Secondary data from the 2016-2018 PNG Demographic and Health Survey (PNGDHS) was used. A total weighted samples of 6,288 married women were included. Complex Sample Analysis method was used to account for the cluster design and sample weight of the study. Chi-square tests and multivariable logistic regression were used to assess factors associated with pregnancy termination. Adjusted odds ratios (aORs) with 95% Confidence Intervals (CIs) were reported.\u0000<strong>Results</strong>\u0000The prevalence of pregnancy termination was 5.3%. Nearly half (45.2%) of all pregnancy terminations occurred in the Highlands region. Women aged 35-44 years (aOR = 8.54; 95% CI: 1.61-45.26), not working (aOR = 6.17; 95% CI: 2.26-16.85), owned a mobile phone (aOR = 3.77; 95% CI: 1.60-8.84), and lived in urban areas (aOR = 5.66; 95% CI: 1.91-16.81) were more likely to terminate a pregnancy. Women who experienced intimate partner violence (IPV) were 2.27 times (aOR = 2.27; 95% CI: 1.17-4.41) more likely to terminate a pregnancy compared to those who did not experience IPV. Women with unplanned pregnancies were 6.23 times (aOR = 6.23; 95% CI: 2.61-14.87) more likely to terminate a pregnancy. Women who knew about modern contraceptive methods and made independent decisions for contraceptive use were 3.38 and 2.54 times (aOR = 3.38; 95% CI: 1.39-8.18 and aOR = 2.54; 95% CI: 1.18-5.45, respectively) more likely to terminate a pregnancy.\u0000<strong>Conclusion</strong>\u0000The findings highlight the role of sociodemographic and maternal factors in pregnancy termination among married women in PNG. Maternal age, occupation, mobile phone ownership, place of residence, IPV, unplanned pregnancy, knowledge of modern contraceptive methods, and decision-maker for contraceptive use were significantly associated with pregnancy termination. Efforts aimed at reducing unplanned pregnancies and terminations should focus on improving easy access to contraceptives and comprehensive sexual and reproductive health education for married couples. Post-abortion care should also be integrated into the country's legal framework and added as an important component of existing sexual and reproductive health services.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141506018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer 在诊断卵巢癌时,无细胞 DNA 比临床和超声波信息更有价值
Pub Date : 2024-06-20 DOI: 10.1101/2024.06.20.24309215
Adriaan Vanderstichele, Jolien Ceusters, Daniela Fischerova, Antonia Testa, Wouter Froyman, Chiara Landolfo, Ruben Heremans, Francesca Moro, Anne-Sophie Van Rompuy, Thaïs Baert, Els Van Nieuwenhuysen, Toon Van Gorp, Ignace Vergote, Pieter Busschaert, Tom Venken, Diether Lambrechts, Joris Robert Vermeesch, Tom Bourne, An Coosemans, Ben Van Calster, Dirk Timmerman
Background: We previously proposed two cfDNA-based scores (genome-wide z-score and nucleosome score) as candidate non-invasive biomarkers to further improve pre-surgical diagnosis of ovarian malignancy. We aimed to investigate the added value of these cfDNA-based scores to the predictors of the ADNEX model (Assessment of Different NEoplasias in the adnexa) to estimate the risk of ovarian malignancy. Methods: 526 patients with an adnexal mass scheduled for surgery were consecutively recruited in three oncology referral centers. cfDNA-based scores were calculated in pre-operative plasma samples. Logistic regression models were fitted for ADNEX predictors alone and after adding cfDNA scores. We reported likelihood ratio tests, the area under the Receiver Operating Characteristic curve (AUC), sensitivity, specificity, and Net Benefit for thresholds between 5% and 40%. Results: The study included 272 benign, 86 borderline, 36 stage I invasive, 113 stage II-IV invasive, and 19 secondary metastatic tumors. The likelihood ratio tests for adding the cfDNA variables to the ADNEX model were statistically significant (p<0.001 for ADNEX without CA125, p=0.001 for ADNEX with CA125). The accompanying increases in AUC were 0.013 and 0.003. Net Benefit, sensitivity and specificity were similar for all models. The increase in Net Benefit at the recommended 10% threshold estimated risk of malignancy was 0.0017 and 0.0020, respectively. According to these results, adding cfDNA markers required at least 453 patients per additional true positive. Conclusion: Although statistically significant, the addition of the cfDNA scores to the ADNEX model do not improve the ADNEX model in a clinically meaningful way.
背景:我们之前提出了两种基于cfDNA的评分(全基因组z-score和核糖体评分)作为候选非侵入性生物标志物,以进一步改善卵巢恶性肿瘤的术前诊断。我们旨在研究这些基于 cfDNA 的评分对 ADNEX 模型(附件不同肿瘤评估)预测指标的附加值,以估算卵巢恶性肿瘤的风险。方法:在三家肿瘤学转诊中心连续招募了 526 名计划接受手术的附件肿块患者,计算术前血浆样本中基于 cfDNA 的评分。对单独的 ADNEX 预测因子和加入 cfDNA 评分后的 ADNEX 预测因子分别拟合了逻辑回归模型。我们报告了似然比检验、接收者操作特征曲线(Receiver Operating Characteristic curve,AUC)下的面积、灵敏度、特异性以及 5% 至 40% 临界值的净收益。研究结果研究包括 272 个良性肿瘤、86 个边缘肿瘤、36 个 I 期浸润性肿瘤、113 个 II-IV 期浸润性肿瘤和 19 个继发性转移肿瘤。在 ADNEX 模型中加入 cfDNA 变量的似然比检验具有统计学意义(不含 CA125 的 ADNEX 的 p<0.001,含 CA125 的 ADNEX 的 p=0.001)。AUC相应增加了0.013和0.003。所有模型的净效益、灵敏度和特异性相似。在推荐的 10%恶性肿瘤估计风险阈值下,净效益分别增加了 0.0017 和 0.0020。根据这些结果,增加 cfDNA 标记每增加一个真阳性至少需要 453 名患者。结论:虽然在统计学上有意义,但在 ADNEX 模型中加入 cfDNA 评分并不能改善 ADNEX 模型的临床意义。
{"title":"Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer","authors":"Adriaan Vanderstichele, Jolien Ceusters, Daniela Fischerova, Antonia Testa, Wouter Froyman, Chiara Landolfo, Ruben Heremans, Francesca Moro, Anne-Sophie Van Rompuy, Thaïs Baert, Els Van Nieuwenhuysen, Toon Van Gorp, Ignace Vergote, Pieter Busschaert, Tom Venken, Diether Lambrechts, Joris Robert Vermeesch, Tom Bourne, An Coosemans, Ben Van Calster, Dirk Timmerman","doi":"10.1101/2024.06.20.24309215","DOIUrl":"https://doi.org/10.1101/2024.06.20.24309215","url":null,"abstract":"Background: We previously proposed two cfDNA-based scores (genome-wide z-score and nucleosome score) as candidate non-invasive biomarkers to further improve pre-surgical diagnosis of ovarian malignancy. We aimed to investigate the added value of these cfDNA-based scores to the predictors of the ADNEX model (Assessment of Different NEoplasias in the adnexa) to estimate the risk of ovarian malignancy. Methods: 526 patients with an adnexal mass scheduled for surgery were consecutively recruited in three oncology referral centers. cfDNA-based scores were calculated in pre-operative plasma samples. Logistic regression models were fitted for ADNEX predictors alone and after adding cfDNA scores. We reported likelihood ratio tests, the area under the Receiver Operating Characteristic curve (AUC), sensitivity, specificity, and Net Benefit for thresholds between 5% and 40%. Results: The study included 272 benign, 86 borderline, 36 stage I invasive, 113 stage II-IV invasive, and 19 secondary metastatic tumors. The likelihood ratio tests for adding the cfDNA variables to the ADNEX model were statistically significant (p&lt;0.001 for ADNEX without CA125, p=0.001 for ADNEX with CA125). The accompanying increases in AUC were 0.013 and 0.003. Net Benefit, sensitivity and specificity were similar for all models. The increase in Net Benefit at the recommended 10% threshold estimated risk of malignancy was 0.0017 and 0.0020, respectively. According to these results, adding cfDNA markers required at least 453 patients per additional true positive. Conclusion: Although statistically significant, the addition of the cfDNA scores to the ADNEX model do not improve the ADNEX model in a clinically meaningful way.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141512534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of quality Antenatal Care utilization in Kenya: insights from the 2022 Kenya Demographic and Health Survey 肯尼亚优质产前护理利用率的决定因素:2022 年肯尼亚人口与健康调查的启示
Pub Date : 2024-06-20 DOI: 10.1101/2024.06.19.24309209
John Baptist Asiimwe, Angella Namulema, Quraish Sserwanja, Joseph Kawuki, Mathius Amperiize, Earnest Amwiine, Lilian Nuwabaine
Introduction: One of the most important strategies to lower mother and newborn fatalities worldwide is providing quality Antenatal care (ANC). The utilization of quality ANC by women of reproductive age and associated factors remains unclear in many developing countries. Therefore, the purpose of this study was to determine the factors associated with the utilization of quality ANC in Kenya. Methods: We analyzed Secondary data from the Kenya Demographic Health Survey (KDHS) 2022, which included 11,863 women. Participants were selected using a two-stage stratified sampling design. Using SPSS, version 20, univariate and multivariable logistic regression was used to analyze the data.Results: Of the 11,863 women, 61.2% (95% CI: 59.7-62.6) received quality ANC. Older mothers (aged 20–34) had a 1.82 (95%CI: 1.15-2.87) times higher likelihood of receiving quality ANC when compared with younger mothers (15–19 years old). Participating mothers who had attended 4 or more ANC visits were 1.42 (95%CI: 1.14-1.79) times more likely to receive quality ANC than those who attended 3 or fewer visits. Comparing participants with and without media access, those with media access were 1.47 (95%CI: 1.06-2.03) times more likely to receive quality ANC. Furthermore, the likelihood of receiving quality ANC was 1.93 (95%CI: 1.21-3.08) and 1.44 (95%CI: 1.01-2.06) times higher for participants in the richest and richer quintiles, respectively, than for those in the poorest quintile. On the contrary, the odds of receiving quality ANC were 0.25 (95%CI: 0.15-0.31) to 0.64 (95%CI: 0.44-0.92) times lower for participating mothers from all other Kenyan regions than for those from the coastal region. Participants whose husbands or partners made decisions for them to seek healthcare, compared with those who made decisions independently were 0.74 (95%CI: 0.58-0.95) times less likely to receive quality antenatal care. Conclusion: The study revealed that about 60% of mothers received quality ANC. Several factors associated with quality ANC were identified: age, region, maternal education, health-seeking decision-making, access to media (TV), time to the health facility, ANC visits, and ANC providers (doctor and nurse/midwife/clinical officer). Maternal health improvement programs should prioritize promoting access to education for girls. Additionally, interventions should focus on promoting shared decision-making and autonomy in healthcare-seeking behaviors among pregnant women and their partners, increasing access to care provided by skilled health workers, and addressing regional disparities in healthcare delivery.
导言:降低全球母亲和新生儿死亡率的最重要战略之一是提供优质的产前保健(ANC)。在许多发展中国家,育龄妇女利用优质产前护理的情况及相关因素仍不清楚。因此,本研究旨在确定肯尼亚优质产前护理利用率的相关因素。方法:我们分析了肯尼亚 2022 年人口健康调查 (KDHS) 的二级数据,其中包括 11,863 名妇女。我们采用两阶段分层抽样设计选取参与者。使用 SPSS 第 20 版对数据进行了单变量和多变量逻辑回归分析:在 11 863 名妇女中,61.2%(95% CI:59.7-62.6)的妇女接受了高质量的产前保健。与年轻母亲(15-19 岁)相比,年龄较大的母亲(20-34 岁)接受优质产前保健的可能性要高出 1.82 倍(95%CI:1.15-2.87)。参加过 4 次或 4 次以上产前检查的母亲接受优质产前检查的可能性是参加过 3 次或 3 次以下产前检查的母亲的 1.42 倍(95%CI:1.14-1.79)。将有机会接触媒体和没有机会接触媒体的参与者进行比较,有机会接触媒体的参与者获得优质产前保健服务的可能性要高出 1.47 倍(95%CI:1.06-2.03)。此外,与最贫穷的五分之一人口相比,最富有和较富有的五分之一人口接受优质产前保健的可能性分别高出 1.93 倍(95%CI:1.21-3.08)和 1.44 倍(95%CI:1.01-2.06)。相反,来自肯尼亚其他地区的母亲接受优质产前保健的几率要比来自沿海地区的母亲低 0.25(95%CI:0.15-0.31)至 0.64(95%CI:0.44-0.92)倍。由丈夫或伴侣决定就医的参试者与独立决定就医的参试者相比,接受优质产前护理的可能性要低 0.74(95%CI:0.58-0.95)倍。结论研究显示,约 60% 的母亲接受了优质的产前保健。与优质产前检查相关的几个因素包括:年龄、地区、产妇教育程度、寻求健康的决策、接触媒体(电视)的机会、前往医疗机构的时间、产前检查次数以及产前检查提供者(医生和护士/助产士/临床官员)。改善产妇健康计划应优先考虑促进女孩接受教育。此外,干预措施应侧重于促进孕妇及其伴侣在寻求医疗保健行为方面的共同决策和自主权,增加由熟练卫生工作者提供医疗保健服务的机会,并解决医疗保健服务提供方面的地区差异。
{"title":"Determinants of quality Antenatal Care utilization in Kenya: insights from the 2022 Kenya Demographic and Health Survey","authors":"John Baptist Asiimwe, Angella Namulema, Quraish Sserwanja, Joseph Kawuki, Mathius Amperiize, Earnest Amwiine, Lilian Nuwabaine","doi":"10.1101/2024.06.19.24309209","DOIUrl":"https://doi.org/10.1101/2024.06.19.24309209","url":null,"abstract":"Introduction: One of the most important strategies to lower mother and newborn fatalities worldwide is providing quality Antenatal care (ANC). The utilization of quality ANC by women of reproductive age and associated factors remains unclear in many developing countries. Therefore, the purpose of this study was to determine the factors associated with the utilization of quality ANC in Kenya. Methods: We analyzed Secondary data from the Kenya Demographic Health Survey (KDHS) 2022, which included 11,863 women. Participants were selected using a two-stage stratified sampling design. Using SPSS, version 20, univariate and multivariable logistic regression was used to analyze the data.\u0000Results: Of the 11,863 women, 61.2% (95% CI: 59.7-62.6) received quality ANC. Older mothers (aged 20–34) had a 1.82 (95%CI: 1.15-2.87) times higher likelihood of receiving quality ANC when compared with younger mothers (15–19 years old). Participating mothers who had attended 4 or more ANC visits were 1.42 (95%CI: 1.14-1.79) times more likely to receive quality ANC than those who attended 3 or fewer visits. Comparing participants with and without media access, those with media access were 1.47 (95%CI: 1.06-2.03) times more likely to receive quality ANC. Furthermore, the likelihood of receiving quality ANC was 1.93 (95%CI: 1.21-3.08) and 1.44 (95%CI: 1.01-2.06) times higher for participants in the richest and richer quintiles, respectively, than for those in the poorest quintile. On the contrary, the odds of receiving quality ANC were 0.25 (95%CI: 0.15-0.31) to 0.64 (95%CI: 0.44-0.92) times lower for participating mothers from all other Kenyan regions than for those from the coastal region. Participants whose husbands or partners made decisions for them to seek healthcare, compared with those who made decisions independently were 0.74 (95%CI: 0.58-0.95) times less likely to receive quality antenatal care. Conclusion: The study revealed that about 60% of mothers received quality ANC. Several factors associated with quality ANC were identified: age, region, maternal education, health-seeking decision-making, access to media (TV), time to the health facility, ANC visits, and ANC providers (doctor and nurse/midwife/clinical officer). Maternal health improvement programs should prioritize promoting access to education for girls. Additionally, interventions should focus on promoting shared decision-making and autonomy in healthcare-seeking behaviors among pregnant women and their partners, increasing access to care provided by skilled health workers, and addressing regional disparities in healthcare delivery.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141512601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphometric Analysis of Spina Bifida after Fetal Repair Shows New Subtypes with Associated Outcomes 胎儿修复后脊柱裂的形态计量分析显示出与相关结果有关的新亚型
Pub Date : 2024-05-29 DOI: 10.1101/2024.05.29.24308088
Lovepreet K. Mann, Shreya Pandiri, Neha Agarwal, Hope Northrup, Kit Sing Au, Elin Grundberg, Eric P. Bergh, Mary T. Austin, Rajan Patel, Brandon Miller, Sen Zhu, Jonathan S. Feinberg, Dejian Lai, KuoJen Tsao, Stephen A. Fletcher, Ramesha Papanna
Importance The binary classification of spina bifida lesions as myelomeningocele (with sac) or myeloschisis (without sac) belies a spectrum of morphologies, which have not been correlated to clinical characteristics and outcomes.
重要性脊柱裂病变被二元分类为髓母细胞瘤(有髓囊)或髓鞘炎(无髓囊),这掩盖了各种形态,而这些形态与临床特征和预后并不相关。
{"title":"Morphometric Analysis of Spina Bifida after Fetal Repair Shows New Subtypes with Associated Outcomes","authors":"Lovepreet K. Mann, Shreya Pandiri, Neha Agarwal, Hope Northrup, Kit Sing Au, Elin Grundberg, Eric P. Bergh, Mary T. Austin, Rajan Patel, Brandon Miller, Sen Zhu, Jonathan S. Feinberg, Dejian Lai, KuoJen Tsao, Stephen A. Fletcher, Ramesha Papanna","doi":"10.1101/2024.05.29.24308088","DOIUrl":"https://doi.org/10.1101/2024.05.29.24308088","url":null,"abstract":"<strong>Importance</strong> The binary classification of spina bifida lesions as myelomeningocele (with sac) or myeloschisis (without sac) belies a spectrum of morphologies, which have not been correlated to clinical characteristics and outcomes.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"106 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141194397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and external validation of an ultrasound image-based deep learning model to estimate gestational age in the second and third trimesters of pregnancy using data from Garbh-Ini cohort: a prospective cohort study in North Indian population 开发基于超声图像的深度学习模型并进行外部验证,利用 Garbh-Ini 队列的数据估计怀孕第二和第三个三个月的胎龄:北印度人群的前瞻性队列研究
Pub Date : 2024-05-14 DOI: 10.1101/2024.05.13.24305466
Divyanshu Mishra, Varun Chandramohan, Nikhil Sharma, Mudita Gosain, Nitya Wadhwa, Uma Chandra Mouli Natchu, GARBH-Ini study group, Ashok Khurana, J. Alison Noble, Ramachandran Thiruvengadam, Bapu Koundinya Desiraju, Shinjini Bhatnagar
Accurate estimation of gestational age (GA) is essential to plan appropriate antenatal care. Current GA estimation models rely on fetal biometry measurements, which are susceptible to ethnic and pathological variations in fetal growth, especially in the second and third trimesters of pregnancy. In this study, we challenge the current paradigm of estimating GA using fetal biometry, by using ultrasound (US) images and deep learning models which can automatically learn image features associated with GA. We developed deep learning models for GA estimation using US images taken at 18-32 weeks of pregnancy from 2207 participants of Garbh-Ini - a hospital-based prospective cohort of pregnant women in North India. Further, we designed a novel conformal prediction (CP) algorithm to detect and reject images when there is a data distribution shift, preventing erroneous predictions. Our best model, GArbh-Ini Ultrasound image-based Gestational age Estimator (GAUGE), which was trained on US images of the fetal head (9647 images from 2207 participants), had a mean absolute error (MAE) of 2.8 days when evaluated on an internal test dataset (N = 204). GAUGE is 44% and 35% more accurate than the widely used Hadlock and INTERGROWTH-21st biometry-based GA models, respectively on the internal test dataset. For an external test dataset (N = 311), collected retrospectively from The Ultrasound Lab, New Delhi, the same model achieved a MAE of 5.9 days. In addition, we show that GAUGE relies on the finer details in the image instead of the fetal biometry and that this leads to a similar performance across small for gestational age (SGA) and appropriate for gestational age (AGA) groups. The ability of GAUGE to consider image features beyond derived biometry suggests that GAUGE offers a better choice for populations with a high prevalence of fetal growth restriction.
准确估计胎龄(GA)对于制定适当的产前保健计划至关重要。目前的胎龄估计模型依赖于胎儿生物测量,而胎儿生物测量容易受到胎儿生长的种族和病理变化的影响,尤其是在怀孕的第二和第三个三个月。在这项研究中,我们利用超声波(US)图像和可自动学习与 GA 相关的图像特征的深度学习模型,对目前使用胎儿生物测量来估计 GA 的模式提出了挑战。我们开发了深度学习模型,利用来自印度北部医院前瞻性孕妇队列 Garbh-Ini 的 2207 名参与者在怀孕 18-32 周时拍摄的 US 图像来估计 GA。此外,我们还设计了一种新颖的保形预测(CP)算法,用于在数据分布发生变化时检测和剔除图像,从而避免错误预测。我们的最佳模型--GArbh-Ini 基于超声图像的妊娠年龄估计器(GAUGE)是在胎儿头部的 US 图像(来自 2207 名参与者的 9647 张图像)上训练出来的,在内部测试数据集(N = 204)上进行评估时,其平均绝对误差(MAE)为 2.8 天。在内部测试数据集上,GAUGE 比广泛使用的 Hadlock 和 INTERGROWTH-21st 基于生物测量的 GA 模型的准确率分别高出 44% 和 35%。对于外部测试数据集(N = 311)(由新德里超声实验室回顾性收集),同一模型的 MAE 为 5.9 天。此外,我们还展示了 GAUGE 依靠图像中更精细的细节而不是胎儿生物测量,这使得小胎龄(SGA)和适龄胎龄(AGA)组的性能相似。高分辨胎儿生长受限的发生率较高,而高分辨胎儿生长受限能够考虑衍生生物测量以外的图像特征,这表明高分辨胎儿生长受限是一种更好的选择。
{"title":"Development and external validation of an ultrasound image-based deep learning model to estimate gestational age in the second and third trimesters of pregnancy using data from Garbh-Ini cohort: a prospective cohort study in North Indian population","authors":"Divyanshu Mishra, Varun Chandramohan, Nikhil Sharma, Mudita Gosain, Nitya Wadhwa, Uma Chandra Mouli Natchu, GARBH-Ini study group, Ashok Khurana, J. Alison Noble, Ramachandran Thiruvengadam, Bapu Koundinya Desiraju, Shinjini Bhatnagar","doi":"10.1101/2024.05.13.24305466","DOIUrl":"https://doi.org/10.1101/2024.05.13.24305466","url":null,"abstract":"Accurate estimation of gestational age (GA) is essential to plan appropriate antenatal care. Current GA estimation models rely on fetal biometry measurements, which are susceptible to ethnic and pathological variations in fetal growth, especially in the second and third trimesters of pregnancy. In this study, we challenge the current paradigm of estimating GA using fetal biometry, by using ultrasound (US) images and deep learning models which can automatically learn image features associated with GA. We developed deep learning models for GA estimation using US images taken at 18-32 weeks of pregnancy from 2207 participants of Garbh-Ini - a hospital-based prospective cohort of pregnant women in North India. Further, we designed a novel conformal prediction (CP) algorithm to detect and reject images when there is a data distribution shift, preventing erroneous predictions. Our best model, GArbh-Ini Ultrasound image-based Gestational age Estimator (GAUGE), which was trained on US images of the fetal head (9647 images from 2207 participants), had a mean absolute error (MAE) of 2.8 days when evaluated on an internal test dataset (N = 204). GAUGE is 44% and 35% more accurate than the widely used Hadlock and INTERGROWTH-21st biometry-based GA models, respectively on the internal test dataset. For an external test dataset (N = 311), collected retrospectively from The Ultrasound Lab, New Delhi, the same model achieved a MAE of 5.9 days. In addition, we show that GAUGE relies on the finer details in the image instead of the fetal biometry and that this leads to a similar performance across small for gestational age (SGA) and appropriate for gestational age (AGA) groups. The ability of GAUGE to consider image features beyond derived biometry suggests that GAUGE offers a better choice for populations with a high prevalence of fetal growth restriction.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141060881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circadian rhythm measured by step count in patients undergoing midline laparotomy for gynaecological conditions 通过步数测量因妇科疾病接受中线开腹手术的患者的昼夜节律
Pub Date : 2024-05-09 DOI: 10.1101/2024.05.08.24307084
Jung Yun Lee, Kidong Kim, Yong Beom Kim, Jae Hong No, Dong Hoon Suh
Objective We aimed to investigate the circadian rhythm of patients undergoing gynaecological surgery using activity log data.
目的 我们旨在利用活动记录数据研究妇科手术患者的昼夜节律。
{"title":"Circadian rhythm measured by step count in patients undergoing midline laparotomy for gynaecological conditions","authors":"Jung Yun Lee, Kidong Kim, Yong Beom Kim, Jae Hong No, Dong Hoon Suh","doi":"10.1101/2024.05.08.24307084","DOIUrl":"https://doi.org/10.1101/2024.05.08.24307084","url":null,"abstract":"<strong>Objective</strong> We aimed to investigate the circadian rhythm of patients undergoing gynaecological surgery using activity log data.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140928707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell characterization of menstrual fluid at homeostasis and in endometriosis 月经液平衡状态和子宫内膜异位症的单细胞表征
Pub Date : 2024-05-06 DOI: 10.1101/2024.05.06.24306766
Petra C. Schwalie, Cemsel Bafligil, Julie Russeil, Magda Zachara, Marjan Biocanin, Daniel Alpern, Evelin Aasna, Bart Deplancke, Geraldine Canny, Angela Goncalves
Progress in detecting and understanding endometrial conditions in women of fertile age, such as endometriosis, has been hampered by the invasiveness of the sample collection procedure. Menstrual fluid (MF) can be sampled non-invasively and could provide a unique opportunity to study the physiological state of tissues in the reproductive system. Despite this potential, the use of MF for diagnostics and research has been limited. Here we establish protocols and assess the feasibility of collecting and processing MF in an outpatient setting. We characterize the cellular contents of MF from 15 healthy women using flow cytometry and single-cell RNA-sequencing, and demonstrate the ability to recover millions of live cells from the different cellular fractions of interest (epithelial, stromal, endothelial, perivascular and blood). Through computational integration of MF with endometrial samples we show that MF sampling is a good surrogate for endometrial biopsy. In a proof-of-principle case-control study, we collect MF from a further 7 women with a diagnosis of endometriosis and 11 healthy controls. Through RNA sequencing of 93 MF samples from these women we highlight important differences between ex vivo and cultured cells, identify impaired decidualisation, low apoptosis, high proliferation, and both higher and lower inflammatory activity in different subsets of immune cells as distinguishing features of endometriosis patients. Finally, we identify potential novel pan-cell-type biomarkers for this neglected condition.
在检测和了解育龄妇女子宫内膜状况(如子宫内膜异位症)方面取得的进展,一直受到样本采集过程的侵入性影响。月经液(MF)可以无创采样,为研究生殖系统组织的生理状态提供了独特的机会。尽管具有这样的潜力,月经液在诊断和研究方面的应用仍然有限。在此,我们制定了在门诊环境中收集和处理 MF 的方案,并评估了其可行性。我们使用流式细胞术和单细胞 RNA 序列分析了 15 名健康女性的 MF 细胞内容物特征,并展示了从不同的细胞组分(上皮细胞、基质细胞、内皮细胞、血管周围细胞和血液细胞)中回收数百万个活细胞的能力。通过将 MF 与子宫内膜样本进行计算整合,我们证明了 MF 采样是子宫内膜活检的良好替代物。在一项原理验证病例对照研究中,我们又从 7 名确诊为子宫内膜异位症的妇女和 11 名健康对照者身上采集了 MF。通过对来自这些妇女的 93 份 MF 样本进行 RNA 测序,我们强调了体内外细胞和培养细胞之间的重要差异,发现蜕膜化受损、凋亡率低、增殖率高以及不同免疫细胞亚群的炎症活性有高有低,这些都是子宫内膜异位症患者的显著特征。最后,我们为这种被忽视的疾病确定了潜在的新型泛细胞型生物标记物。
{"title":"Single-cell characterization of menstrual fluid at homeostasis and in endometriosis","authors":"Petra C. Schwalie, Cemsel Bafligil, Julie Russeil, Magda Zachara, Marjan Biocanin, Daniel Alpern, Evelin Aasna, Bart Deplancke, Geraldine Canny, Angela Goncalves","doi":"10.1101/2024.05.06.24306766","DOIUrl":"https://doi.org/10.1101/2024.05.06.24306766","url":null,"abstract":"Progress in detecting and understanding endometrial conditions in women of fertile age, such as endometriosis, has been hampered by the invasiveness of the sample collection procedure. Menstrual fluid (MF) can be sampled non-invasively and could provide a unique opportunity to study the physiological state of tissues in the reproductive system. Despite this potential, the use of MF for diagnostics and research has been limited. Here we establish protocols and assess the feasibility of collecting and processing MF in an outpatient setting. We characterize the cellular contents of MF from 15 healthy women using flow cytometry and single-cell RNA-sequencing, and demonstrate the ability to recover millions of live cells from the different cellular fractions of interest (epithelial, stromal, endothelial, perivascular and blood). Through computational integration of MF with endometrial samples we show that MF sampling is a good surrogate for endometrial biopsy. In a proof-of-principle case-control study, we collect MF from a further 7 women with a diagnosis of endometriosis and 11 healthy controls. Through RNA sequencing of 93 MF samples from these women we highlight important differences between <em>ex vivo</em> and cultured cells, identify impaired decidualisation, low apoptosis, high proliferation, and both higher and lower inflammatory activity in different subsets of immune cells as distinguishing features of endometriosis patients. Finally, we identify potential novel pan-cell-type biomarkers for this neglected condition.","PeriodicalId":501409,"journal":{"name":"medRxiv - Obstetrics and Gynecology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140929067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
medRxiv - Obstetrics and Gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1